161 related articles for article (PubMed ID: 25449147)
1. Dual optical modality endoscopic imaging of cancer development in the mouse colon.
Keenan MR; Leung SJ; Rice PS; Wall RA; Barton JK
Lasers Surg Med; 2015 Jan; 47(1):30-9. PubMed ID: 25449147
[TBL] [Abstract][Full Text] [Related]
2. Expanding Functionality of Commercial Optical Coherence Tomography Systems by Integrating a Custom Endoscope.
Welge WA; Barton JK
PLoS One; 2015; 10(9):e0139396. PubMed ID: 26418811
[TBL] [Abstract][Full Text] [Related]
3. In vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis.
Leung SJ; Rice PS; Barton JK
Lasers Surg Med; 2015 Jan; 47(1):40-9. PubMed ID: 25487746
[TBL] [Abstract][Full Text] [Related]
4. In vivo endoscopic Doppler optical coherence tomography imaging of the colon.
Welge WA; Barton JK
Lasers Surg Med; 2017 Mar; 49(3):249-257. PubMed ID: 27546786
[TBL] [Abstract][Full Text] [Related]
5. Serial endoscopy in azoxymethane treated mice using ultra-high resolution optical coherence tomography.
Hariri LP; Qiu Z; Tumlinson AR; Besselsen DG; Gerner EW; Ignatenko NA; Povazay B; Hermann B; Sattmann H; McNally J; Unterhuber A; Drexler W; Barton JK
Cancer Biol Ther; 2007 Nov; 6(11):1753-62. PubMed ID: 17986850
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of azoxymethane-induced aberrant crypt foci in inbred mice.
Delker DA; Wang QS; Papanikolaou A; Whiteley HE; Rosenberg DW
Exp Mol Pathol; 1999 Feb; 65(3):141-9. PubMed ID: 10234360
[TBL] [Abstract][Full Text] [Related]
7. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
Whiteley LO; Hudson L; Pretlow TP
Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
[TBL] [Abstract][Full Text] [Related]
8. Magnifying colonoscopy as a non-biopsy technique for differential diagnosis of non-neoplastic and neoplastic lesions.
Kato S; Fu KI; Sano Y; Fujii T; Saito Y; Matsuda T; Koba I; Yoshida S; Fujimori T
World J Gastroenterol; 2006 Mar; 12(9):1416-20. PubMed ID: 16552812
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
10. Adenomas and carcinomas may be histologically detected in apparently normal colonic mucosa. A study of carcinogen-treated rats.
Rubio CA; Jaramillo E; Sethye J
In Vivo; 2001; 15(4):299-301. PubMed ID: 11695221
[TBL] [Abstract][Full Text] [Related]
11. Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice.
Hata K; Yamada Y; Kuno T; Hirose Y; Hara A; Qiang SH; Mori H
Cancer Sci; 2004 Apr; 95(4):316-20. PubMed ID: 15072589
[TBL] [Abstract][Full Text] [Related]
12. Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility.
Papanikolaou A; Wang QS; Delker DA; Rosenberg DW
Cancer Lett; 1998 Aug; 130(1-2):29-34. PubMed ID: 9751253
[TBL] [Abstract][Full Text] [Related]
13. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
14. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis.
Papanikolaou A; Wang QS; Papanikolaou D; Whiteley HE; Rosenberg DW
Carcinogenesis; 2000 Aug; 21(8):1567-72. PubMed ID: 10910960
[TBL] [Abstract][Full Text] [Related]
15. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods.
Tudek B; Bird RP; Bruce WR
Cancer Res; 1989 Mar; 49(5):1236-40. PubMed ID: 2917353
[TBL] [Abstract][Full Text] [Related]
16. Magnifying endoscopy with indigo carmine contrast for differential diagnosis of neoplastic and nonneoplastic colonic polyps.
Su MY; Ho YP; Chen PC; Chiu CT; Wu CS; Hsu CM; Tung SY
Dig Dis Sci; 2004 Aug; 49(7-8):1123-7. PubMed ID: 15387332
[TBL] [Abstract][Full Text] [Related]
17. Automated quantification of colonic crypt morphology using integrated microscopy and optical coherence tomography.
Qi X; Pan Y; Hu Z; Kang W; Willis JE; Olowe K; Sivak MV; Rollins AM
J Biomed Opt; 2008; 13(5):054055. PubMed ID: 19021435
[TBL] [Abstract][Full Text] [Related]
18. Perspectives of chromo and magnifying endoscopy: how, how much, when, and whom should we stain?
Kiesslich R; Jung M; DiSario JA; Galle PR; Neurath MF
J Clin Gastroenterol; 2004 Jan; 38(1):7-13. PubMed ID: 14679320
[TBL] [Abstract][Full Text] [Related]
19. In vivo molecular imaging of colorectal cancer using quantum dots targeted to vascular endothelial growth factor receptor 2 and optical coherence tomography/laser-induced fluorescence dual-modality imaging.
Carbary-Ganz JL; Welge WA; Barton JK; Utzinger U
J Biomed Opt; 2015; 20(9):096015. PubMed ID: 26397238
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
